• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>iShares S&P 1500 Index

iShares S&P 1500 Index

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Relvar® Ellipta® 100/25 mcg Gains Approval in Japan for Use in Patients with COPD

    Relvar® Ellipta® 100/25 mcg Gains Approval in Japan for Use in Patients with COPD

  2. Veeva to Present at Upcoming Investor Conferences

    Veeva to Present at Upcoming Investor Conferences

  3. Athene Holding Ltd. Announces the Launch of Its Initial Public Offering

    Athene Holding Ltd. Announces the Launch of Its Initial Public Offering

  4. UPDATE: What Eli Lilly's hard fall in Alzheimer's treatment race means for its competitors

    UPDATE: What Eli Lilly's hard fall in Alzheimer's treatment race means for its competitors

  5. UPDATE: What Eli Lilly's hard fall in Alzheimer's treatment race means for its competitors

    UPDATE: What Eli Lilly's hard fall in Alzheimer's treatment race means for its competitors

  6. UPDATE: What Eli Lilly's hard fall in Alzheimer's treatment race means for its competitors

    UPDATE: What Eli Lilly's hard fall in Alzheimer's treatment race means for its competitors

  7. VW to Take Ax To German Jobs -- WSJ

    VW to Take Ax To German Jobs -- WSJ

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.